Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teh-Ia Huo

Showing results (151-160 of 229) with videos related to

Pageof 23
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2025
Gender Different Impacts of Muscle Mass and Adipose Tissue on Patients With Hepatocellular Carcinoma Undergoing Surgical ResectionPei-Chang Lee, Tsung-Yi Cheng, Chun-Ting Ho, et al.
Scientific Reports|March 21, 2018
Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resectionShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Scientific Reports|October 23, 2020
Author Correction: Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Digestive Diseases and Sciences|October 30, 2019
A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan CriteriaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastroenterology and Hepatology|October 17, 2015
2'-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosisI-Fang Hsin, Jing-Yi Lee, Teh-Ia Huo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 21, 2011
Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysisChia-Yang Hsu, Yi-Hsiang Huang, Yi-You Chiou, et al.
Plos One|May 2, 2015
The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced CirrhosisHung-Chun Tung, Fa-Yauh Lee, Sun-Sang Wang, et al.
Journal of Hepatology|January 17, 2012
Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled studyChiun Hsu, Tsai-Sheng Yang, Teh-Ia Huo, et al.
Molecular Nutrition & Food Research|December 1, 2020
Active Vitamin D<sub>3</sub> Treatment Attenuated Bacterial Translocation via Improving Intestinal Barriers in Cirrhotic RatsPei-Chang Lee, Yun-Chen Hsieh, Teh-Ia Huo, et al.
Scientific Reports|October 12, 2018
Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Pageof 23

Showing results (151-160 of 229) with videos related to

Sort By:
Pageof 23
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2025
Gender Different Impacts of Muscle Mass and Adipose Tissue on Patients With Hepatocellular Carcinoma Undergoing Surgical ResectionPei-Chang Lee, Tsung-Yi Cheng, Chun-Ting Ho, et al.
Scientific Reports|March 21, 2018
Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resectionShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Scientific Reports|October 23, 2020
Author Correction: Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Digestive Diseases and Sciences|October 30, 2019
A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan CriteriaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastroenterology and Hepatology|October 17, 2015
2'-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosisI-Fang Hsin, Jing-Yi Lee, Teh-Ia Huo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 21, 2011
Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysisChia-Yang Hsu, Yi-Hsiang Huang, Yi-You Chiou, et al.
Plos One|May 2, 2015
The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced CirrhosisHung-Chun Tung, Fa-Yauh Lee, Sun-Sang Wang, et al.
Journal of Hepatology|January 17, 2012
Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled studyChiun Hsu, Tsai-Sheng Yang, Teh-Ia Huo, et al.
Molecular Nutrition & Food Research|December 1, 2020
Active Vitamin D<sub>3</sub> Treatment Attenuated Bacterial Translocation via Improving Intestinal Barriers in Cirrhotic RatsPei-Chang Lee, Yun-Chen Hsieh, Teh-Ia Huo, et al.
Scientific Reports|October 12, 2018
Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Pageof 23